Hypoxia-active nanoparticles used in tumor theranostic
Yaqin Wang,1,2,* Wenting Shang,2,* Meng Niu,1 Jie Tian,2,3 Ke Xu11Department of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, People’s Republic of China; 2Chinese Academy of Sciences Key Laboratory of Molecular Imaging, Institute of Automati...
Guardado en:
Autores principales: | Wang Y, Shang W, Niu M, Tian J, Xu K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a7faf8af2e448eca941ebe53cc6a5a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment
por: Zheng D, et al.
Publicado: (2020) -
Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy
por: Wang W, et al.
Publicado: (2020) -
A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting
por: Liu Y, et al.
Publicado: (2017) -
Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
por: Tang L, et al.
Publicado: (2021) -
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi Y, et al.
Publicado: (2018)